Your session is about to expire
← Back to Search
18F-OP-801 for Lou Gehrig's Disease
Study Summary
This trial will study the safety and how 18F-OP-801 (18F Hydroxyl Dendrimer) behaves in the body after being given intravenously to patients with ALS and healthy volunteers.
- Lou Gehrig's Disease
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Awards & Highlights
Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Has recruitment for this clinical research commenced?
"The clinical trial's information hosted on clinicaltrials.gov suggest that this investigation is not currently recruiting, having been initially posted on July 15th 2022 and last edited on May 25th 2022. Despite this, there are 547 other medical trials actively seeking patients right now."
Is 18F-OP-801 a secure compound to use for human consumption?
"Since 18F-OP-801 is currently undergoing Phase 1 trials, the safety rating for this drug was assessed as a 1 due to incomplete evidence of both efficacy and risk."
Is eligibility for this clinical research open to senior citizens?
"Applicants to this medical trial must be between 18 and 80 years old in order to meet the set criteria. In addition, there are 44 trials for minors and 402 studies available that cater specifically towards individuals aged 65 or higher."
Is it possible for me to enrol in this medical experiment?
"For this medical trial, 25 adult patients (aged 18-80) living with amyotrophic lateral sclerosis are being accepted. Participants must be able to comprehend and consent to the Informed Consent Form as well meet other criteria including: sterilization or postmenopausal status for women of non-childbearing potential, contraception use by both sexes, abstinence from sperm donation in males, negative pregnancy test results in reproductive females."
Share this study with friends
Copy Link
Messenger